Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway.
The Opportunity:
The Director, Global Value, Access & Pricing – CRC is responsible for developing and driving global access and pricing strategies for Revolution Medicines’ CRC assets to enable timely, sustainable patient access across key markets. This role ensures payer and HTA requirements are embedded into clinical development, indication sequencing, and launch planning from early-stage development through commercialization.
The Director serves as the global access lead on cross-functional asset teams and partners closely with HEOR, Clinical Development, Regulatory, Commercial, Finance, and Regional Market Access to align global strategy with regional execution.
Key responsibilities:
Lead development of global pricing and market access strategies for CRC assets, including launch sequencing, reference pricing considerations, and price corridor management across priority markets.
Identify payer-relevant evidence requirements and partner with HEOR to align evidence generation plans with global reimbursement needs.
Assess CRC competitive dynamics, including line-of-therapy positioning, biomarker-driven access considerations, and combination therapy reimbursement implications.
Guide EU Joint Clinical Assessment (JCA) strategy and submission preparation in collaboration with regional Market Access and HEOR teams.
Build and maintain strong relationships with Clinical, Commercial, Regulatory, HEOR, and Medical Affairs functions.
Provide strategic direction to regional teams on pricing implementation, reimbursement risk mitigation, and negotiation readiness.
Contribute to Global Market Access capability-building efforts to strengthen organizational knowledge and effectiveness.
Provide strategic market access input into clinical development programs to optimize endpoints, comparators, and evidence packages for payer and HTA success.
Monitor, analyze, and communicate global access and pricing trends, competitor activities, and policy changes.
Contribute access and pricing assessments to lifecycle planning and business development evaluations.
Required Skills, Experience and Education:
Bachelor’s degree required; advanced degree Ph.D., PharmD, MD, or MSc in Health Economics, Public Health, Health Policy, or a related field preferred.
10+ years of relevant experience in market access and pricing, ideally with global leadership exposure.
Strong experience in pricing & reimbursement of oncology products.
Deep understanding of global payer systems and HTA processes, including AMNOG, Chuikyo, NICE, and other EU frameworks.
Experience designing and implementing global pricing strategy, including value-based pricing, launch sequencing, and reference pricing mitigation.
Experience with pricing regulations, early pricing analysis, and pricing negotiations (country level experience preferred).
Demonstrated ability to support clinical development to satisfy payer/HTA evidence needs.
Experience engaging HTA and payer organizations in early advice to inform development and trial strategies.
Preferred Skills:
Strategic and analytical thinking with strong problem-solving skills.
Excellent communication, leadership, and cross-functional collaboration abilities.
Proven track record influencing decisions and driving results in a matrix organization.
Fluency in English; additional languages are a plus.
#LI-Remote #LI-JW1
The base pay salary range for this full-time position for candidates working onsite at our headquarters in Redwood City, CA is listed below. The range displayed on each job posting is intended to be the base pay salary range for an individual working onsite in Redwood City and will be adjusted for the local market a candidate is based in. Our base pay salary ranges are determined by role, level, and location. Individual base pay salary is determined by multiple factors, including job-related skills, experience, market dynamics, and relevant education or training.
Please note that base pay salary range is one part of the overall total rewards program at RevMed, which includes competitive cash compensation, robust equity awards, strong benefits, and significant learning and development opportunities.
Revolution Medicines is an equal opportunity employer and prohibits unlawful discrimination based on race, color, religion, gender, sexual orientation, gender identity/expression, national origin/ancestry, age, disability, marital status, medical condition, and veteran status.
Revolution Medicines takes protection and security of personal data very seriously and respects your right to privacy while using our website and when contacting us by email or phone. We will only collect, process and use any personal data that you provide to us in accordance with our CCPA Notice and Privacy Policy. For additional information, please contact [email protected].
We are aware of recent recruitment scams in which individuals or organizations falsely represent themselves as being affiliated with Revolution Medicines. These scams may appear as false job advertisements or unsolicited contacts through communication or chat platforms, email, phone, or text message.
Please note that Revolution Medicines does not extend unsolicited employment offers and will never ask candidates to provide financial information, purchase equipment, or pay fees as part of the hiring process. All legitimate communication from Revolution Medicines will come from an official @revmed.com email address.
If you believe you’ve been contacted by someone impersonating a Revolution Medicines recruiter, please report it to [email protected] so we can share these impersonations with our IT team for tracking and awareness.
Similar Jobs
.png){kind=logo}
.png)
What you need to know about the Charlotte Tech Scene
Key Facts About Charlotte Tech
- Number of Tech Workers: 90,859; 6.5% of overall workforce (2024 CompTIA survey)
- Major Tech Employers: Lowe’s, Bank of America, TIAA, Microsoft, Honeywell
- Key Industries: Fintech, artificial intelligence, cybersecurity, cloud computing, e-commerce
- Funding Landscape: $3.1 billion in venture capital funding in 2024 (CED)
- Notable Investors: Microsoft, Google, Falfurrias Management Partners, RevTech Labs Foundation
- Research Centers and Universities: University of North Carolina at Charlotte, Northeastern University, North Carolina Research Campus
